The Apex Times
Above the Noise
Business Wire
BusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessPalantir’s premium valuation raises a tougher question for shareholders: what exactly is being priced inThe Apex TimesBusinessCaterpillar shares give back gains after a sharp early-October tumbleThe Apex TimesBusinessKFC’s U.S. Coca-Cola switch outlines a fresh pull for The Coca-Cola Company as PepsiCo loses a key refreshment tapThe Apex TimesBusinessTesla’s Flying Roadster Revives SpaceX Comparisons, but Investors Say It’s Not a Product Roadmap ItemThe Apex TimesBusinessBattery X Metals draws attention at Tesla-hosted venue for X Takeover 2026 electric-vehicle and emerging-tech eventThe Apex TimesBusinessFounder of $13k MRR lifting app says Meta beats TikTok for early app marketingThe Apex TimesBusinessBristol-Myers Squibb screens cheaper than Johnson & Johnson, but leverage and patent overhang drive the debateThe Apex TimesBusinessStarlink Mobile raises a question for Apple: could US carrier subsidies come under pressure?The Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessPalantir’s premium valuation raises a tougher question for shareholders: what exactly is being priced inThe Apex TimesBusinessCaterpillar shares give back gains after a sharp early-October tumbleThe Apex TimesBusinessKFC’s U.S. Coca-Cola switch outlines a fresh pull for The Coca-Cola Company as PepsiCo loses a key refreshment tapThe Apex TimesBusinessTesla’s Flying Roadster Revives SpaceX Comparisons, but Investors Say It’s Not a Product Roadmap ItemThe Apex TimesBusinessBattery X Metals draws attention at Tesla-hosted venue for X Takeover 2026 electric-vehicle and emerging-tech eventThe Apex TimesBusinessFounder of $13k MRR lifting app says Meta beats TikTok for early app marketingThe Apex TimesBusinessBristol-Myers Squibb screens cheaper than Johnson & Johnson, but leverage and patent overhang drive the debateThe Apex TimesBusinessStarlink Mobile raises a question for Apple: could US carrier subsidies come under pressure?The Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessPalantir’s premium valuation raises a tougher question for shareholders: what exactly is being priced inThe Apex TimesBusinessCaterpillar shares give back gains after a sharp early-October tumbleThe Apex TimesBusinessKFC’s U.S. Coca-Cola switch outlines a fresh pull for The Coca-Cola Company as PepsiCo loses a key refreshment tapThe Apex TimesBusinessTesla’s Flying Roadster Revives SpaceX Comparisons, but Investors Say It’s Not a Product Roadmap ItemThe Apex TimesBusinessBattery X Metals draws attention at Tesla-hosted venue for X Takeover 2026 electric-vehicle and emerging-tech eventThe Apex TimesBusinessFounder of $13k MRR lifting app says Meta beats TikTok for early app marketingThe Apex TimesBusinessBristol-Myers Squibb screens cheaper than Johnson & Johnson, but leverage and patent overhang drive the debateThe Apex TimesBusinessStarlink Mobile raises a question for Apple: could US carrier subsidies come under pressure?The Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessPalantir’s premium valuation raises a tougher question for shareholders: what exactly is being priced inThe Apex TimesBusinessCaterpillar shares give back gains after a sharp early-October tumbleThe Apex TimesBusinessKFC’s U.S. Coca-Cola switch outlines a fresh pull for The Coca-Cola Company as PepsiCo loses a key refreshment tapThe Apex TimesBusinessTesla’s Flying Roadster Revives SpaceX Comparisons, but Investors Say It’s Not a Product Roadmap ItemThe Apex TimesBusinessBattery X Metals draws attention at Tesla-hosted venue for X Takeover 2026 electric-vehicle and emerging-tech eventThe Apex TimesBusinessFounder of $13k MRR lifting app says Meta beats TikTok for early app marketingThe Apex TimesBusinessBristol-Myers Squibb screens cheaper than Johnson & Johnson, but leverage and patent overhang drive the debateThe Apex TimesBusinessStarlink Mobile raises a question for Apple: could US carrier subsidies come under pressure?The Apex Times
Back to front
Johnson & Johnson raises dividend again, extending 64-year streak
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 13, 3:39 PM EDT

Johnson & Johnson raises dividend again, extending 64-year streak

The company said its dividend increased by 3.1%, bringing the annual payout to $5.36 per share, after more than six decades of consecutive increases.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Johnson & Johnson has increased its dividend for a 64th consecutive year, according to a market report dated Aug. 13, 2026.

The report says the new dividend rate represents a 3.1% increase and values the annual dividend at $5.36 per share. The company’s long-running streak is one of the longest in the U.S. large-cap market, reflecting an unusually steady approach to returning cash to shareholders through multiple economic cycles.

Because the cited post is focused on the dividend change and the resulting income example, it does not provide full details in the text available here, such as the quarterly dividend amount, the payment dates, or the specific board action cadence that typically accompanies dividend changes.

The post also frames the headline figure around a hypothetical $10,000 investment, implying a straightforward relationship between per-share dividends and share count. However, without the underlying share-price or share-count assumptions displayed in the accessible text, the exact annual dollar figure for a $10,000 investment cannot be independently verified from what is provided here.

Dividend increases can be especially important for mature, cash-generating healthcare companies because they compete for investors who prioritize dependable cash returns. In that context, extending a multi-decade increase record can help stabilize demand for the shares, even when investors debate near-term earnings growth.

Johnson & Johnson, trading on the New York Stock Exchange under the ticker JNJ, is often discussed by investors as a “dividend growth” candidate in the healthcare sector. The report’s emphasis on a new annualized dividend rate underscores that investors are still measuring the company’s capital allocation through its ability to lift payouts consistently.

Still, the market post does not, in the material available here, disclose how the dividend increase was supported by underlying free cash flow, nor does it describe whether management’s broader guidance changed alongside the increase.

What investors will likely watch next is whether subsequent quarterly dividend declarations continue to track the same upward pace, and whether the company pairs its dividend record with updates on cash generation, pricing, and demand trends across its businesses.

Why It Matters

  • A long dividend growth streak is often viewed as a announcement of cash-return discipline for investors in mature sectors like healthcare.
  • A 3.1% step-up in the annual dividend rate can affect investor sentiment, particularly among shareholders that prioritize income.
  • Dividend policy can influence how markets interpret management’s confidence in sustained earnings and cash flow, even if growth headlines are muted.
  • The lack of detailed financial context in the cited post means investors may still need to consult company filings or investor materials to connect the dividend change to fundamentals.

Sources

Key Facts

  • Johnson & Johnson increased its dividend for 64 consecutive years, according to a market report dated Aug. 13, 2026.
  • The reported dividend increase was 3.1%.
  • The report says the annual dividend rate is $5.36 per share.
  • The report frames the update in part through an income example tied to a hypothetical $10,000 investment.
  • The company is listed on the NYSE under ticker JNJ.

Healthcare Related

Johnson & Johnson raises dividend again, extending 64-year streak | The Apex Times